tiprankstipranks
Surmodics earnings selloff a buying opportunity, says Barrington
PremiumThe FlySurmodics earnings selloff a buying opportunity, says Barrington
3M ago
Surmodics ‘methodically preparing for a new phase of growth,’ says Lake Street
PremiumThe Fly
Surmodics ‘methodically preparing for a new phase of growth,’ says Lake Street
3M ago
Surmodics sees FY24  EPS ($1.17)- (87c), consensus ($1.16)
PremiumThe Fly
Surmodics sees FY24 EPS ($1.17)- (87c), consensus ($1.16)
3M ago
Surmodics management to meet with Barrington
PremiumThe FlySurmodics management to meet with Barrington
4M ago
Surmodics announces 36-month data from TRANSCEND trial
PremiumThe Fly
Surmodics announces 36-month data from TRANSCEND trial
6M ago
Surmodics announces 24-month data from SWING trial
PremiumThe Fly
Surmodics announces 24-month data from SWING trial
6M ago
Surmodics reports Q3 EPS 52c, consensus 5c
PremiumThe FlySurmodics reports Q3 EPS 52c, consensus 5c
10M ago
Surmodics price target raised to $69 from $60 at Barrington
PremiumThe Fly
Surmodics price target raised to $69 from $60 at Barrington
11M ago
Surmodics announces FDA approval of SurVeil drug-coated balloon
PremiumThe Fly
Surmodics announces FDA approval of SurVeil drug-coated balloon
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100